TY - JOUR
T1 - Neural signatures of conditioning, extinction learning, and extinction recall in posttraumatic stress disorder
T2 - A meta-analysis of functional magnetic resonance imaging studies
AU - Suarez-Jimenez, Benjamin
AU - Albajes-Eizagirre, Anton
AU - Lazarov, Amit
AU - Zhu, Xi
AU - Harrison, Ben J.
AU - Radua, Joaquim
AU - Neria, Yuval
AU - Fullana, Miquel A.
N1 - Publisher Copyright:
Copyright © Cambridge University Press 2019.
PY - 2020/7/1
Y1 - 2020/7/1
N2 - Background Establishing neurobiological markers of posttraumatic stress disorder (PTSD) is essential to aid in diagnosis and treatment development. Fear processing deficits are central to PTSD, and their neural signatures may be used as such markers.Methods Here, we conducted a meta-analysis of seven Pavlovian fear conditioning fMRI studies comparing 156 patients with PTSD and 148 trauma-exposed healthy controls (TEHC) using seed-based d-mapping, to contrast neural correlates of experimental phases, namely conditioning, extinction learning, and extinction recall.Results Patients with PTSD, as compared to TEHCs, exhibited increased activation in the anterior hippocampus (extending to the amygdala) and medial prefrontal cortex during conditioning; in the anterior hippocampus-amygdala regions during extinction learning; and in the anterior hippocampus-amygdala and medial prefrontal areas during extinction recall. Yet, patients with PTSD have shown an overall decreased activation in the thalamus during all phases in this meta-analysis.Conclusion Findings from this metanalysis suggest that PTSD is characterized by increased activation in areas related to salience and threat, and lower activation in the thalamus, a key relay hub between subcortical areas. If replicated, these fear network alterations may serve as objective diagnostic markers for PTSD, and potential targets for novel treatment development, including pharmacological and brain stimulation interventions. Future longitudinal studies are needed to examine whether these observed network alteration in PTSD are the cause or the consequence of PTSD.
AB - Background Establishing neurobiological markers of posttraumatic stress disorder (PTSD) is essential to aid in diagnosis and treatment development. Fear processing deficits are central to PTSD, and their neural signatures may be used as such markers.Methods Here, we conducted a meta-analysis of seven Pavlovian fear conditioning fMRI studies comparing 156 patients with PTSD and 148 trauma-exposed healthy controls (TEHC) using seed-based d-mapping, to contrast neural correlates of experimental phases, namely conditioning, extinction learning, and extinction recall.Results Patients with PTSD, as compared to TEHCs, exhibited increased activation in the anterior hippocampus (extending to the amygdala) and medial prefrontal cortex during conditioning; in the anterior hippocampus-amygdala regions during extinction learning; and in the anterior hippocampus-amygdala and medial prefrontal areas during extinction recall. Yet, patients with PTSD have shown an overall decreased activation in the thalamus during all phases in this meta-analysis.Conclusion Findings from this metanalysis suggest that PTSD is characterized by increased activation in areas related to salience and threat, and lower activation in the thalamus, a key relay hub between subcortical areas. If replicated, these fear network alterations may serve as objective diagnostic markers for PTSD, and potential targets for novel treatment development, including pharmacological and brain stimulation interventions. Future longitudinal studies are needed to examine whether these observed network alteration in PTSD are the cause or the consequence of PTSD.
KW - Conditioning
KW - extinction
KW - fMRI
KW - meta-analysis
KW - posttraumatic stress disorder
KW - recall
UR - http://www.scopus.com/inward/record.url?scp=85068360793&partnerID=8YFLogxK
U2 - 10.1017/S0033291719001387
DO - 10.1017/S0033291719001387
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 31258096
AN - SCOPUS:85068360793
SN - 0033-2917
VL - 50
SP - 1442
EP - 1451
JO - Psychological Medicine
JF - Psychological Medicine
IS - 9
ER -